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1. Introduction 
Conjunctivitis can be broadly classified into two groups, infectious and noninfectious. 
Infectious conjunctivitis is mainly caused by bacteria (60%), followed by viruses (20%), with 
the remaining cases caused by Chlamydia, fungi and parasites. Infectious conjunctivitis 
tends to present during the summer months. 
Non-infectious conjunctivitis includes allergic causes, often during the flowering period in 
spring. However, nosocomial outbreaks and work related conditions, as well as mechanical 
and functional causes are not associated with any particular time of year.  
Conjunctivitis can also be divided into epidemic and non-epidemic, associated with risk 
factors, immunological factors, and mechanical-functional causes. This classification allows 
professionals to tailor patient care more effectively. 
1.1 Epidemic conjunctivitis 
There are several pathogens reported to be able to affect large groups and cause greater or 
wider than expected epidemics. However, conjunctivitis has caused several epidemics in the 
past and although most cases are benign and self-limiting, many underestimate its impact 
on the population and its ability to spread rapidly. 
Epidemic types of conjunctivitis, especially hemorrhagic types, are subject to surveillance by 
world health systems. They are more common in the summer and one of their main features 
is the rapid spread and numbers of cases that occur in short periods of time. Some serotypes 
are widely distributed, and these are usually those which show this epidemic capability.1,2 
Conjunctivitis can be transmitted efficiently by virtually all known methods of transmission 
(see Modes of transmission), which partly explains the rapidity of its spread. 
It is known that acute hemorrhagic conjunctivitis occurs in tropical areas due to high 
temperatures and high relative humidity, which prolongs the survival of viruses. Other viral 
intrinsic factors, such as in adenovirus, allow viral establishment in adverse environments, 
and these factors are associated with epidemics. It is increasingly becoming clear that 
medical staff also participate in the spread of an epidemic, as the handling of patients 
without appropriate risk management can make medical personnel a disease vector. 
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Cases of epidemic hemorrhagic conjunctivitis are mainly caused by adenovirus. However, 
coxsackie A24 is currently responsible for the reported worldwide epidemic. It was first 
identified in Ghana in 1969, later spread to Asia and Oceania, and at the end of the twentieth 
century regular reports of events caused by several strains of coxsackievirus had been 
published.3-9 This epidemic affected several countries in all continents including Australia, 
where an acute conjunctivitis caused by coxsackie A24 in a non-.hemorrhagic form was 
identified.10-12 (Figure 1). 
 
 
Fig. 1. Distribution of epidemic hemorrhagic conjunctivitis caused by coxsackie A24. In red, 
countries that presented with hemorrhagic conjunctivitis; in blue, countries that presented 
with non-hemorrhagic conjunctivitis. 
1.2 Non-epidemic conjunctivitis  
Conjunctivitis is a disease that represents a significant proportion of ophthalmologist 
consultations. Usually, non-epidemic forms of this condition do not have the potential to 
affect large populations, but its impact is on medical spending, temporary disability and in 
rare cases, steps to contain a possible outbreak. 
The main cause of non-epidemic conjunctivitis is allergic conjunctivitis. As a group, they 
represent the main reason for consultation for conjunctivitis in developed countries and 
have also shown an increase in prevalence and incidence. 
Allergic conjunctivitis is a very common disorder in adults as well as in children. The 
estimations of its incidence, reported in the literature, vary from 15 to 25 % of the general 
population.13  
Allergic conjunctivitis includes 5 clinical entities (classes), such as Seasonal Allergic 
Conjunctivitis (SAC), occurring most frequently, followed by Atopic Keratoconjunctivitis 
(AKC), Vernal Keratoconjunctivitis (VKC), Perennial Allergic Conjunctivitis (PAC) and 
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Giant Papillary Conjunctivitis (GPC). The SAC and PAC occur in relatively mild forms, 
while VKC and AKC, in which also cornea is affected, and represent more severe, often 
bilateral, forms. The GPC appears only sporadically.14  
Allergic conjunctivitis is associated with common allergens; is common to find that sufferers 
also have atopy and a family history of allergy. This type of conjunctivitis occurs most often 
between 10 and 40 years of life, peaking in the second decade. 
The most frequently involved allergens are: I. Various inhalant allergens, such as pollen 
species, Dermatophagoides pteronyssinus, Dermatophagoides farinae, various moulds (Aspergillus 
fumigatus, Aspergillus niger, Alternaria family, Cladosporium family, Penicillium family, Candida 
albicans, Thermopolyspora polyspora), animal danders (hairs, feathers, squamae), organic dusts, 
some foods in powder form (flour kinds, spices); II. Some drugs (e.g. in powder form, 
ointments, etc); III. Digested foods; IV. Contact allergens.15  
Some cases of conjunctivitis are associated with chemical or physical agents inherent in 
patients’ work conditions and occupational hazards. Among these chemicals, the most 
common causes of work-related conjunctivitis are mepacrine, ammonia and vanadium, 
mainly linked to the metalworking industry. In the case of physical agents, ultraviolet light 
received in outdoor occupations such as police and construction work is the main cause of 
conjunctivitis. 
Another type of occupational hazard associated with conjunctivitis is the handling of 
infected secretions. This can present a high risk to medical staff that provides care to 
patients if appropriate hygiene measures are not taken. 
The remaining conjunctivitis cases can be attributed to bacteria, parasites, fungi and viruses 
(non-epidemic serotypes), which are also an important cause of daily ophthalmic 
consultations. However, these should be tackled depending on the causative factor. These 
types of conjunctivitis can be considered as nosocomial outbreaks, as they are mainly 
acquired in hospitals (e.g. Staphylococcus sp., adenovirus, herpes virus and Candida spp., 
among others).  
2. Risk factors  
2.1 Environmental risk factors, host susceptibility and pathogen factors  
Conjunctivitis is not distributed randomly; cases manifest when increasing risk factors 
converge. Like other diseases that affect humans, it occurs on the conjunction of three 
factors: the causative agent, the environment and host specific factors.  
Allergic conjunctivitis requires both a significant interaction of the environment and the 
individual's susceptibility to develop allergic conditions. The major known risk factors are a 
history of asthma or multiple allergies, smoking, contact lenses and environmental pollution.13  
On the other hand, infectious conjunctivitis depends on the specific capabilities of the 
infective agent, though the human factor is also important as humans can often act as a 
disease reservoir.  
Theoretically, we are all susceptible to conjunctivitis, but its presentation may depend more 
on risks associated with patient contact or contaminated materials. It has, however, been 
observed that age and sex are important factors, with children, young adults and women 
being the main groups affected. 
There are 2 basic forms of allergic conjunctivitis with respect to the localization of the initial 
allergic reaction (antigen-antibody or antigen-sensitized Th1-cells interaction with subsequent 
steps). In the primary form of allergic conjunctivitis, the allergic reaction, due to direct 
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exposure of Conjunctiva to an external allergen, occurs in the conjunctival mucosa. In this case, 
the conjunctiva is the primary and solely site of the allergic reaction with all subsequent steps, 
resulting in the development of the primary (classical) form of allergic conjunctivitis. In the 
secondary form of allergic conjunctivitis, the initial allergic reaction takes place in other 
(related) organ, mostly in the nasal mucosa, due to the direct exposure of nasal mucosa to an 
external allergen, leading to release of various factors (mediators, cytokines, chemokines and 
other factors), which can then reach conjunctiva by various ways, such as lacrimal system, 
blood, lymphatic or neurogenic network, and induce there the secondary conjunctival 
response (secondarily induced allergic conjunctivitis). In principle, all five clinical classes of 
allergic conjunctivitis can occur either in a primary or in a secondary form.14,16  
Various hypersensitivity (immunologic) mechanisms can be involved in all five clinical 
classes of allergic conjunctivitis, both in their primary and in their secondary forms. The 
immediate (IgE-mediated) hypersensitivity mechanism, upon participation of the IgE 
antibodies, mast cells, eosinophils, epithelial cells and Th2-cells also designated as atopy, 
having been often studied and well documented, has been confirmed as the most frequent 
mechanism underlying the allergic conjunctivitis. 
However, the evidence for involvement and causal role of other so-called non-immediate 
(non-IgE-mediated) hypersensitivity mechanisms, such as late (Type III) and delayed (Type 
IV, cell-mediated) in the allergic conjunctivitis of all five classes, is growing and became to 
be recognized.17-19 The existence of the primary and secondary form of the allergic 
conjunctivitis as well as particular types of conjunctival response can only be demonstrated 
by provocation tests with allergen. 
The conjunctival provocation tests with allergen confirm the primary allergic conjunctivitis 
form, whereas the nasal provocation tests with allergen upon monitoring of objective 
conjunctival signs and subjective symptoms confirm the secondary (secondarily induced) 
conjunctivitis form. Patients with both the forms of allergic conjunctivitis can develop 
various types of conjunctival response to allergen challenge, such as immediate (early), late 
or delayed response, depending on the type of hypersensitivity mechanism(s) involved.19-21  
2.2 Immune response and risk factors 
Epidemic keratoconjunctivitis caused by adenovirus induces a strong acute inflammatory 
response. Efforts have been made to identify host factors that promote and influence the 
severity of the clinical picture, with the purpose of generating an idea of prognosis. Among the 
factors to be studied, the immune response is important, as this may influence the damage 
done by the disease. The mechanisms that decide the initial response of the host depends on 
the innate immune response mediated by proinflammatory cytokines. These are essential in 
establishing the adaptive immune response, which provides long term protection.  
Recently, the study of receptors in the cells involved with the innate immune response has 
received particular attention. The early interactions between pathogens and host cells are 
critical in the establishment of the infection. These receptors, known as Pattern Recognition 
Receptors (PRRs), recognize molecular patterns of pathogens (PAMP) that are highly 
conserved, and manage the effectiveness of the adaptive immune response that may limit or 
exacerbate the infection.22 It has been shown that human Toll-like receptors (TLRs) play an 
essential role in triggering the innate immune response, recognizing a variety of PAMPs 
associated with bacteria, viruses, protozoa and fungi. The signals initiated by the interaction 
of TLRs with specific antigen ligands direct the inflammatory response, which attempts to 
eliminate the pathogen and start the adaptive response. In humans, eleven TLRs have been 
identified (TLR1-TLR11).22,23  
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The TLR2 receptor is particularly important, as it has a unique mechanism of ligand 
recognition where it cooperates with other TLR family members, particularly TLR1 and 
TLR6.24 There are several studies showing that herpes simplex virus type 1 (HSV1), type 2 
(HSV2), cytomegalovirus (CMV) and respiratory syncytial virus (RSV) induce TLR2-
dependent proinflammatory cytokines in an attempt to induce cell protection.25-27  
On the other hand, single nucleotide polymorphisms (SNPs) in genes encoding TLRs have 
also been reported. The TLR2 Arg677Trp and Arg753Gln SNPs are associated with 
susceptibility and severity of viral infections.25-28 In our laboratory we found the Phe707Phe 
polymorphism in the Mexican population, with an allelic frequency of 7.5% and this 
suggests that this SNP not affect our population.29  
The first line of defense against viruses is interferons. However, proinflammatory cytokines 
and antimicrobial peptides also promote the cell-mediated immune response, which is 
essential for the resolution of infection.30 Beta-defensins (HBDs) act as antimicrobial 
peptides in humans and are also effective against a variety of microorganisms.31  
In immunoprivileged tissue such as the cornea, the complex mechanisms that prevent the 
induction of inflammation and the behavior of cytokines and peptides of the innate 
immune response must be tightly regulated. An infection may then upset this 
microenvironment and cause damage to the ocular surface. Adenovirus infections induce 
expression of IP-10 and I-TAC, defense peptides against Ad5 and Ad3 respectively. It is 
suggested that epidemic strains of adenovirus (Ad8 and Ad19) could be resistant to these 
defensins. Interestingly, HBDs have also been suggested to possess an additional 
protective effect that contributes to the corneal healing process.32,33  
Genetic variants at the promoter region of the beta defensin-1 (DEFB-1) gene are 
uncommon, however recent reports showed three SNPs that affect gene expression.34,35 
These -20A/-44C/-52G haplotypes have all been associated with chronic lung infection with 
P. aeruginosa.36 The -44C allele also predisposes to infection by HIV37,38 and Candida spp.39 
Moreover, Carter et al also found that it strongly associated with endophthalmitis.40 In a 
recent study in our laboratory, we found a significantly higher frequency of -44C and -52G 
DEFB-1 polymorphisms in a cohort of 30 samples taken from patients with adenovirus 
infection. These showed an increased risk of infection of 2.86 for -44C allele and 2.44 for 
allele -52 G. These findings indicate that genotypes -44C/G and -52G/G may be associated 
with adenovirus infection (data not reported). The results obtained in the works above 
represent preliminary studies that require analysis of larger populations worldwide to 
determine whether these polymorphisms can be used as marker of infection susceptibility. 
3. Transmission  
Infectious conjunctivitis has a transmission capability dependant on the etiological agent 
involved. 
Bacterial conjunctivitis is highly contagious and is associated with close contact between 
patients, a situation common in kindergartens and childcare. This predisposes to constant 
outbreaks, but these are rarely identified as children gradually leave the disease area.  
Viruses, particularly respiratory adenovirus, which produces pharingoconjunctivitis also 
have a high capability of infection and is often confused with Streptococcus pneumoniae. 
Fungi have a low transmission capability, but can be transmitted more efficiently amongst 
the sick or immunocompromised. 
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4. Forms of transmission 
Conjunctivitis is most commonly transmitted by direct contact with secretions from a sick 
patient. However, air droplet transmission is also common, as well as via vehicles such as 
Hyppelates spp., which act as a vector for bacterial transmission. 
4.1 Contact transfer 
Transmission by contact with a contaminated body surface is the usual transfer mechanism 
for staphylococci, streptococci and enterobacteria. This is also the classic mechanism of 
transmission of nosocomial infections. Hand washing and use of protective barriers such as 
gloves and lab coats are sufficient to prevent transmission, as well as changing the dose of 
medication. Despite the fact that protective measures are simple, compliance is difficult and 
may become costly. However, contact transmission is responsible for a large proportion of 
cases, which implies that control of basic hygiene may reduce the case load significantly. 
4.2 Droplet transmission 
This transmission occurs through close contact with a patient. The droplets have a diameter 
greater than 5μm and are generated by coughing, sneezing, talking and during certain 
health care procedures. 
Transmission occurs when droplets are deposited on the Conjunctiva or nasal mucosa of a 
susceptible host. The droplets travel an average distance of one meter from the patient and 
quickly fall to the ground. Therefore, transmission does not occur at greater distances and 
drops are not kept in the air for long periods, so special air handling is not required to 
prevent transmission by this mechanism.  
4.3 Air transmission 
This occurs through close or medium range contact with a patient. The droplets in this case 
have a diameter less than 5μm and are generated from an infected person during breathing, 
speech, coughing and sneezing. 
Transmission occurs when microorganisms containing droplets generated by an infected 
person dry and remain airborne for long periods of time. These organisms (usually viruses) 
can be dispersed widely by air currents and inhaled by a susceptible host within the same 
room or even at distance depending on environmental factors, so in this case air handling 
and ventilation are important to prevent contagion. This type of transmission is less 
common but control is more expensive and complex.  
4.4 Transmission by vectors 
Transmission by vector is not considered widely relevant, but it is well known that 
Chlamydia can be transmitted by flies. 
In the case of trachoma, which starts as a follicular conjunctivitis, it has been documented 
that the housefly (Hyppelates spp.) facilitates the transfer of infected secretions from patients 
to others. 
5. Outbreaks 
Conjunctivitis has high potential for nosocomial outbreaks depending on the causative 
agent, and has the capability to affect a large number of people. One of the most important 
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features of these outbreaks is the speed of propagation, but with the appearance of a benign 
condition. Its importance lies in allowing us a panoramic view of the strengths and 
weaknesses of the systems of epidemiological surveillance in hospitals.  
5.1 Microorganisms involved in outbreaks 
5.1.1 Bacterial 
5.1.1.1 Acute infections 
The most common outbreaks are produced by Staphylococcus spp., Streptococcus spp., and 
Haemophilus sp. Some patients may be positive in culture for Pneumococcus sp.  
Crum et al. described an outbreak of Streptococcus pneumoniae in 92 of 3500 soldiers.41 Martin 
et al also reported an outbreak affecting 698 college students with this organism.42 In 
another report, Haemophilus influenzae was shown to be responsible for 428 cases in Israel.43  
5.1.1.2 Hyperacute infections 
Hyperacute bacterial conjunctivitis is most frequently caused by Neisseria gonorrhoeae, related 
to oculopharingeal disorders in neonates and in sexually active young people. In 1987 and 
1988, there were over 9,000 cases of conjunctivitis caused by N. gonorrhoeae in Ethiopia and 
children under 5 years were the group primarily affected.44 The aboriginal population of 
central Australia has also has been frequently affected, with 447 cases reported in 1997.45  
5.1.1.3 Chronic infections 
Staphylococcus aureus is the bacteria most commonly reported in the literature as causing 
chronic conjunctivitis.  
5.1.1.4 Chlamydial conjunctivitis 
Conjunctivitis is considered chronic after 4 weeks and the best known cases of chronic 
follicular conjunctivitis are caused by Chlamydia trachomatis. This bacterium also causes 
cervicitis in women and urethritis and epididymitis in men. Unfortunately, these clinical 
manifestations may occur as subclinical infections, preventing the detection of the bacteria.  
The newborn of women carrying Chlamydia trachomatis have a high incidence of 
conjunctivitis and pneumonia. In adults, conjunctivitis appears to be transmitted primarily 
by contact with infected genital discharge and usually occurs as isolated individual 
episodes, with few progressing to eye symptoms.46,47  
On the other hand, in areas endemic for trachoma the first contact with C. trachomatis is 
related to the prevalence of infection in the community. Trachoma is clinically characterized 
by the presence of papillae and follicular inflammation of the tarsal conjunctiva and is 
referred to as active trachoma.48 Trachoma can be produced by serovars A-C (A, B, Ba and 
C) of C. trachomatis and is endemic in 55 countries around the world.49 Serovars D-K 
(genitals) may also affect the neonatal conjunctiva. It has also been reported that the species 
Chlamydophila pneumoniae and Chlamydophila psittaci may also cause trachoma, and may 
cause polyinfection with C. trachomatis.50 However, as trachoma is a chronic infection, it 
does not usually cause epidemics. 
5.1.2 Viral infections 
Viruses are the principal cause of conjunctivitis worldwide, with adenovirus and 
coxsackievirus being the most frequent. It is reported that follicular conjunctivitis can occur 
as part of the pharynx and respiratory syndrome, or as a separate entity.  
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5.1.2.1 Pharyingoconjunctival fever caused by adenovirus 
This disease is often accompanied by lymphadenopathy and most commonly associated 
with genotypes of the subgenera B and E (Ad3, Ad7 and Ad4).51-53  
5.1.2.2 Epidemic keratoconjunctivitis 
This severe form of conjunctivitis caused by adenovirus can incapacitate the patient for 
several weeks. The aftermath of the infection can leave subepithelial infiltrates that may 
affect the visual field. Outbreaks are caused by subgenus D (AD8, and AD37 Ad19).54,55  
5.1.2.3 Acute hemorrhagic conjunctivitis 
The coxsackieviruses, which are subtypes of enterovirus from the family Picornaviridae are 
usually responsible for this infection. (See Epidemic conjunctivitis). The greatest number of 
reports of conjunctivitis worldwide is shown on this webpage (http://www.prome-
dmail.org). This page shows that since 2003, coxsackievirus A24 has been responsible for 
most outbreaks, followed by avian influenza conjunctivitis (H1N1).  
5.1.2.4 Herpes conjunctivitis  
Herpes (HSV) conjunctivitis produces insidious and recurrent forms, and therefore can be 
very difficult to eradicate. HSV1 causes the typical forms of herpetic keratitis but HSV2 
conjunctivitis has also been reported in infants or adults with sexual herpes. In 1989, an 
outbreak of HSV1 in a school population in Minneapolis in Minnesota, USA affected 175 
children, of which HSV1 was isolated in 35%.56  
5.2 Prevention and control of outbreaks  
Prevention and control of outbreaks of conjunctivitis are subject to support by the work in 
hospitals, community and laboratories. 
Initially, it is essential to have a formal or informal surveillance (epidemiological work) to 
monitor infections that can commonly affect the health of a group. For example, causes of 
hemorrhagic conjunctivitis are subject to surveillance by national health systems of many 
countries.  
One of the most important components in the presentation of any outbreak is medical and 
nursing staff who may become a source of contagion. This failure is due to widespread use 
of antibiotics and insufficient cleaning of surfaces and equipment due to reduced vigilance 
by medical staff and unsafe risk management. Hence, the use of preventive measures is 
necessary to cut the chain of transmission. Contact isolation is also critical to preventing 
outbreaks in institutions and should be strictly executed.  
During epidemics, emphasis should be put on preventing the spread of infection, which is 
achieved by careful hand washing, cleaning and meticulous handling of objects that have 
been in contact with eye or respiratory secretions. It is also critical to consider that patients 
are contagious until the symptoms disappear completely.  
The following is highly recommended:  
 Wash hands immediately after treating or handling secretions from a patient diagnosed 
with probable or confirmed conjunctivitis. Hand washing should be performed even 
when latex gloves were used.  
 Use gloves and lab coat if in contact with a patient or their body fluids.  
 Use of personal protective measures when conducting procedures that may generate 
splashes to mucous membranes of the staff.  
 Restrict access of health staff only to those who have direct patient responsibility. 
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 Medical equipment (apparatus and instruments) as well as chairs and tables of should 
be scrupulously disinfected to prevent contamination of other patients and/or health 
personnel.  
 Patients should be isolated or grouped with other patients with an active infection with 
the same pathogen. It is important to restrict access to family, particularly in the case of 
neonates, infants or immunocompromised individuals. The material used with patients 
should be disposable equipment, or if that is not possible the equipment should be 
disinfected.  
5.3 Outbreak vigilance 
Preventive measures have the effect of decreasing the frequency and severity of outbreaks, 
however, personnel should be prepared to efficiently deal with them should they arise. 
It is necessary to follow a methodology to reach containment of the outbreak to contain the 
damage to the population by: identifying risk factors, controlling sources of infection, 
implementation of interventions to prevent additional cases and breaking the chain of 
transmission. 
The outbreak vigilance involves four phases (Figure 2):  
i. Knowledge of the problem  
ii. Critical phase (decision making) 
iii. Care phase  
iv. Resolution phase  
 
 
Fig. 2. Outbreak vigilance algorithm: I) Knowledge of the problem, II) Decision making, III) 
Attention of the outbreak and IV) Problem resolution. 
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Stage I requires detection of conjunctivitis cases and confirmation either in the hospital or 
the community. In Stage II, decisions are made to deal with extreme conditions and guide 
further action. The critical phase is essential, as it is necessary to react to suspected cases and 
identify the infectious agent in order that efficient control measures can be undertaken. This 
also allows the search for the pathogen in the environment or community (particularly in 
cases with contact transmission), as well as establishment of accurate diagnostic tests.57-61  
5.4 Laboratory assays 
The clinical manifestations of conjunctivitis suggest the possible etiology of infection, but 
the diagnosis should be confirmed by laboratory testing. 
The type of inflammatory response (papillary, follicular, membranous, pseudomembranous 
or ulcerative granulomatous), time of onset, intensity and duration of inflammation (acute 
or chronic), type of discharge (mucoid, purulent or watery) and associated symptoms 
(itching, foreign body sensation) should be carefully evaluated and taken into consideration 
to establish a presumptive diagnosis. 
Generally, bacterial conjunctivitis presents with diffusing conjunctival injection, conjunctival 
chemosis, papillary hypertrophy (in areas of conjunctiva firmly attached, such as the tarsus 
and semilunar fold) and purulent discharge. 
The most frequent causative organisms with this pathology are Staphylococcus spp, 
Neisseria gonorrhoeae or N. meningitidis, Streptococcus pneumoniae, Pseudomonas aeruginosa or 
Escherichia coli. 
Follicular conjunctivitis is characterized by tearing, mucopurulent discharge, redness, 
conjunctival follicles and cellular infiltration. It can be diagnosed as acute or chronic according 
to onset and duration of inflammation. Causes of acute follicular conjunctivitis include: acute 
adenovirus infection (pharyngoconjunctival fever), epidemic keratoconjunctivitis, herpes 
simplex, varicella zoster, and viral influenza. In contrast, chronic cases are caused by Chlamydia 
spp., toxic follicular conjunctivitis (molluscum contagiosum of lid margin, response to topical 
medications), Moraxella spp. and Actinomyces israelli (infection of the canaliculus).  
The clinical diagnosis of conjunctivitis can be confirmed by several techniques based on 
microbiological examination of ocular samples. There are often two difficulties in identification 
and microbiological diagnosis in ocular infections. The first is the small amount of sample 
obtained from the eye; the second is the need to obtain a result in a short time to give timely 
treatment to the patient. 
Tests performed for the identification of microorganisms in eye infections include classic 
microbiological tests, such as stains and cultures, as well as the use of molecular techniques 
such as real-time PCR. Both types of methodology are suitable for the identification of 
infectious organisms; however, they both have advantages and disadvantages. The classic 
tests can identify infectious organisms with near certainty, but can take a long time. Real-
time PCR offers results in a short time, as well as high sensitivity, but has high costs and not 
all hospitals are able to offer this test routinely.  
Based on our experience, we developed an algorithm for identification of microorganisms 
that cause conjunctivitis (Figure 3). Here we show how a presumptive clinical diagnosis is 
confirmed by real-time PCR.  
Molecular techniques to identify microorganisms at species level allow tailoring of 
therapy to the etiological agent. On the other hand, the use of microbiological culture is 
not ruled out completely, as these can be used for confirmatory studies. Automated 
sequencing of 16S ribosomal genes to identify bacterial species may also be important for 
epidemiological studies. 
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Fig. 3. Algorithm for identification of the causative agent of conjunctivitis. 
5.5 Knowledge phase 
 Formal notification sources: Weekly reporting of new cases, cases with poor outcomes, 
case study reporting, etc.  
 Informal notification sources: Radio, television and other communication media. 
 Comparison of the observed and expected incidence, mortality and morbidity statistics 
from affected area, as well as national and international spread.  
 Information gathering: go to the affected area to verify the existence of outbreak. 
 Confirm the diagnosis to ensure that the problem has been properly assessed  (medical 
and laboratory assessment etc.).  
 Association of two or more cases in time, place and person.  
 Verify the presence or not of "artifacts" that could give false positive or negatives 
(intentional awareness campaigns, changes in case definition, implementation  of new 
diagnostic tests, etc.).  
 Standardize criteria for deciding the criteria for determining if a suspected patient is 
involved in the outbreak.  
 Construct an operational definition of a case with: 
- Syndromic approach  
- Simple and clear 
- Broad enough to include all cases (sensitive) but restricted enough to capture only 
the affected group (specific).  
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5.6 Critical phase 
 Know the number of cases treated or untreated by health staff (especially in community 
cases where there are other forms of health care).  
 Give immediate attention to reducing the impact of the disease in the population. 
 Strengthen health measures.  
 Conduct a syndromic approach.  
 Focus on known risk factors with measures to cut the chain of transmission. 
 Carry out bacteriological control (if necessary).  




 Search the environment for propagating agents.  
 Apply diagnostic battery for potential agents.  
 Differential diagnosis.  
 Analysis of environmental samples.  
5.7 Resolution phase 
This stage should give health advice to reduce the risk of affecting a larger population, and 
this should be tailored to the source, mode of transmission and exposure duration. 
6. Conclusions 
Conjunctivitis is one of the most common infections worldwide, which is associated with its 
significant potential for infection and spread as well as human factors that govern inherent 
susceptibility to infection. 
Infectious conjunctivitis is responsible for many nosocomial and community outbreaks, as it 
may be transmitted by virtually all known routes. It is also responsible for epidemics and 
pandemics, such as the current hemorrhagic conjunctivitis outbreak caused by coxsackie A24. 
Conjunctivitis, like many conditions, is not randomly distributed and requires a convergence 
of risk factors: genetic, immunological, environmental and pathogen-related. These risk 
factors are very broad in the case of conjunctivitis and there is the additional complication of 
fly vector transmission of trachoma and follicular conjunctivitis. 
Epidemiological knowledge of conjunctivitis allows us to identify and react promptly to 
control outbreaks based on the determination of the source and the re-establishment of 
sanitary measures and basic hygiene. 
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